Tempest Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Tempest Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2020 to 2023.
  • Tempest Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was -$5K, a 97.4% increase year-over-year.
  • Tempest Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $103K.
  • Tempest Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$334K, a 68.8% increase from 2022.
  • Tempest Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was -$1.07M, a 18.8% increase from 2021.
  • Tempest Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was -$1.32M, a 1562% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$334K +$735K +68.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-19
2022 -$1.07M +$247K +18.8% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-19
2021 -$1.32M -$1.41M -1562% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $90K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.